Related Experiment Videos
Doppler echocardiography
1Mount Sinai Medical Center of Greater Miami, Miami, Florida.
Summary
Doppler echocardiography now offers quantitative cardiac imaging and hemodynamics. Advanced techniques precisely measure mitral regurgitation and assess diastolic function, particularly in cardiac amyloidosis.
Area of Science:
- Cardiovascular Imaging
- Hemodynamics
- Echocardiography
Background:
- Doppler echocardiography is evolving the cardiac echo laboratory into a comprehensive cardiac imaging and hemodynamics laboratory.
- Blood flow evaluation in cardiac chambers and great vessels is transitioning from semiquantitative to quantitative methods.
Purpose of the Study:
- To highlight the advancements in Doppler echocardiography for quantitative cardiac imaging and hemodynamics.
- To demonstrate the precise measurement of mitral regurgitant flow and its application in assessing cardiac function.
Main Methods:
- Utilizing Doppler echocardiography to evaluate flow acceleration zones on the left ventricular side of the mitral valve.
- Employing transesophageal Doppler echocardiography for direct imaging of pulmonary venous return.
- Calculating the pressure/time ratio from continuous wave Doppler spectra for left ventricular systolic function assessment.
Main Results:
- Precise measurement of mitral regurgitant flow is achievable by analyzing flow acceleration zones.
- Transesophageal Doppler echocardiography enables more accurate quantification of mitral regurgitation.
- Doppler-derived transmitral flow analysis is practically applied to evaluate diastolic function, including in cardiac amyloidosis.
Conclusions:
- Doppler echocardiography provides quantitative hemodynamic assessment, enhancing cardiac imaging capabilities.
- The technology allows for precise quantification of mitral regurgitation and improved assessment of left ventricular systolic function.
- Transmitral flow analysis using Doppler echocardiography is a valuable tool for evaluating diastolic function, with demonstrated utility in cardiac amyloidosis.